Actively Recruiting
"Smart Family Doctor" Assisted Comprehensive Management of Secondary Prevention Among Post Coronary Artery Bypass Graft Patients or Post Percutaneous Coronary Intervention Patients
Led by China National Center for Cardiovascular Diseases · Updated on 2025-12-08
536
Participants Needed
1
Research Sites
59 weeks
Total Duration
On this page
Sponsors
C
China National Center for Cardiovascular Diseases
Lead Sponsor
C
Chinese Academy of Medical Sciences, Fuwai Hospital
Collaborating Sponsor
AI-Summary
What this Trial Is About
This study aims to evaluate the effect of an AI-assisted "Smart family doctor" digital health management tool on improving the control rates of hypertension, diabetes, and dyslipidemia in post-CABG (coronary artery bypass grafting) patients or post-PCI (percutaneous coronary intervention) patients. A randomized controlled trial design will be used, involving approximately 5-10 hospitals and 536 participants. Eligible participants are adults aged 18 or older, post-CABG or post-PCI patients with hypertension, diabetes, and dyslipidemia.
CONDITIONS
Official Title
"Smart Family Doctor" Assisted Comprehensive Management of Secondary Prevention Among Post Coronary Artery Bypass Graft Patients or Post Percutaneous Coronary Intervention Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older
- History of CABG surgery or PCI with hypertension, diabetes, and dyslipidemia
- At least one of the following: systolic blood pressure ≥ 130 mmHg or diastolic blood pressure ≥ 80 mmHg, HbA1c ≥ 7%, LDL-C ≥ 1.4 mmol/L
- Use of a smartphone
- Signed informed consent
You will not qualify if you...
- History of heart failure or severe arrhythmias
- Severe underlying conditions such as cancer or liver and kidney insufficiency
- Pregnancy, lactation, or plans for pregnancy within the next year
- Cognitive or communication impairments or limitations in daily activities
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Xinjiang's First Affiliated Hospital of medical university
Ürümqi, Xinjiang, China, 102300
Actively Recruiting
Research Team
L
Lihua Zhang Zhang, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here